These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Roles of hybrid donepezil scaffolds as potent human acetylcholinesterase inhibitors using in silico interaction analysis, drug-likeness, and pharmacokinetics prediction. Honorio P; Hannongbua S; Saparpakorn P Chem Biol Interact; 2022 Dec; 368():110227. PubMed ID: 36302488 [TBL] [Abstract][Full Text] [Related]
3. Identification of Human Acetylcholinesterase Inhibitors from the Constituents of EGb761 by Modeling Docking and Molecular Dynamics Simulations. Zhang L; Li D; Cao F; Xiao W; Zhao L; Ding G; Wang ZZ Comb Chem High Throughput Screen; 2018; 21(1):41-49. PubMed ID: 29173156 [TBL] [Abstract][Full Text] [Related]
4. Metal based donepezil analogues designed to inhibit human acetylcholinesterase for Alzheimer's disease. Junaid M; Islam N; Hossain MK; Ullah MO; Halim MA PLoS One; 2019; 14(2):e0211935. PubMed ID: 30785927 [TBL] [Abstract][Full Text] [Related]
5. N-(4-Hydroxyphenyl)-3,4,5-trimethoxybenzamide derivatives as potential memory enhancers: synthesis, biological evaluation and molecular simulation studies. Piplani P; Sharma M; Mehta P; Malik R J Biomol Struct Dyn; 2018 May; 36(7):1867-1877. PubMed ID: 28565938 [TBL] [Abstract][Full Text] [Related]
6. Binding interaction of protoberberine alkaloids against acetylcholinesterase (AChE) using molecular dynamics simulations and QM/MM calculations. Honorio P; Sainimnuan S; Hannongbua S; Saparpakorn P Chem Biol Interact; 2021 Aug; 344():109523. PubMed ID: 34033838 [TBL] [Abstract][Full Text] [Related]
7. Molecular docking and receptor-specific 3D-QSAR studies of acetylcholinesterase inhibitors. Deb PK; Sharma A; Piplani P; Akkinepally RR Mol Divers; 2012 Nov; 16(4):803-23. PubMed ID: 22996404 [TBL] [Abstract][Full Text] [Related]
8. Piperazine-2-carboxylic acid derivatives as MTDLs anti-Alzheimer agents: Anticholinesterase activity, mechanistic aspect, and molecular modeling studies. Soliman AM; Abd El-Wahab HAA; Akincioglu H; Gülçin İ; Omar FA Bioorg Chem; 2024 Jan; 142():106916. PubMed ID: 37913584 [TBL] [Abstract][Full Text] [Related]
9. Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer's disease. Zhou A; Hu J; Wang L; Zhong G; Pan J; Wu Z; Hui A J Mol Model; 2015 Oct; 21(10):277. PubMed ID: 26438408 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, molecular modeling studies, ADME prediction of arachidonic acid carbamate derivatives, and evaluation of their acetylcholinesterase activity. Kalin TN; Kilic D; Arslan F; Colak O; Altundas A Drug Dev Res; 2020 Apr; 81(2):232-241. PubMed ID: 31758816 [TBL] [Abstract][Full Text] [Related]
12. Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease. Gurung AB; Aguan K; Mitra S; Bhattacharjee A J Biomol Struct Dyn; 2017 Jun; 35(8):1729-1742. PubMed ID: 27410776 [TBL] [Abstract][Full Text] [Related]
13. Computational studies of acetylcholinesterase complexed with fullerene derivatives: a new insight for Alzheimer disease treatment. da Silva Gonçalves A; França TC; Vital de Oliveira O J Biomol Struct Dyn; 2016 Jun; 34(6):1307-16. PubMed ID: 26219766 [TBL] [Abstract][Full Text] [Related]
14. Bioactive sulfonyl hydrazones with alkyl derivative: Characterization, ADME properties, molecular docking studies and investigation of inhibition on choline esterase enzymes for the diagnosis of Alzheimer's disease. Bilen E; Özdemir Özmen Ü; Çete S; Alyar S; Yaşar A Chem Biol Interact; 2022 Jun; 360():109956. PubMed ID: 35452634 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of a New Class of Spirooxindole-Benzo[ Barakat A; Alshahrani S; Al-Majid AM; Ali M; Altowyan MS; Islam MS; Alamary AS; Ashraf S; Ul-Haq Z Molecules; 2020 Oct; 25(20):. PubMed ID: 33066293 [TBL] [Abstract][Full Text] [Related]
16. Ceanothanes Derivatives as Peripheric Anionic Site and Catalytic Active Site Inhibitors of Acetylcholinesterase: Insights for Future Drug Design. Pastene-Burgos S; Muñoz-Nuñez E; Quiroz-Carreño S; Pastene-Navarrete E; Espinoza Catalan L; Bustamante L; Alarcón-Enos J Int J Mol Sci; 2024 Jul; 25(13):. PubMed ID: 39000410 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, extra-precision docking, and molecular dynamics simulation studies of pyrrolidin-2-one derivatives as potential acetylcholinesterase inhibitors. Gupta M; Kumar A; Prasun C; Nair MS; Kini SG; Yadav D; Nain S J Biomol Struct Dyn; 2023; 41(13):6282-6294. PubMed ID: 35921217 [TBL] [Abstract][Full Text] [Related]
18. Identification of potential bivalent inhibitors from natural compounds for acetylcholinesterase through in silico screening using multiple pharmacophores. Lakshmi V; Kannan VS; Boopathy R J Mol Graph Model; 2013 Mar; 40():72-9. PubMed ID: 23353586 [TBL] [Abstract][Full Text] [Related]
19. Identification of novel acetylcholinesterase inhibitors through e-pharmacophore-based virtual screening and molecular dynamics simulations. Malik R; Choudhary BS; Srivastava S; Mehta P; Sharma M J Biomol Struct Dyn; 2017 Nov; 35(15):3268-3284. PubMed ID: 27782777 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of novel naturally-inspired multifunctional molecules for the management of Alzheimer's disease. Singh YP; Tej GNVC; Pandey A; Priya K; Pandey P; Shankar G; Nayak PK; Rai G; Chittiboyina AG; Doerksen RJ; Vishwakarma S; Modi G Eur J Med Chem; 2020 Jul; 198():112257. PubMed ID: 32375073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]